Sign in

NCT06417931Completed

Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD

A Pharmacist-Led Intervention on Medication Adherence and Inhaler Usage on Clinical Outcomes Among Patients With Asthma and Chronic Obstructive Pulmonary Disease in Ibadan, Nigeria

Source: ClinicalTrials.gov · Last updated 16 May 2024

Brief summary (registry, in English)

This study aims to evaluate the impact of a pharmacist-led intervention programme on medication adherence and use of inhaler devices on clinical outcomes of patients with asthma and COPD attending a tertiary health facility in Nigeria.

Status (registry)
Completed
Study type
Interventional
Enrollment
130 (actual)
First submitted
13 May 2024
Start date
4 Oct 2023
Primary completion date
28 Feb 2024
Lead sponsor
University of Ibadan
Diseases
Asthma, COPD
NCT number
NCT06417931

What you commit to

  • Study type: Interventional
  • Participants enrolled: 130
  • From 4 Oct 2023 to the primary completion date, 28 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • All non-consenting patients and patients who are not on any medications at any point in the study

Who the study is looking for

  • Patients 18 years of age and older with a primary diagnosis of asthma or COPD by a physician who are willing to complete the study and have telephone access

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University College Hospital
Coordinator of this site? Confirm its status
IbadanNigeriaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.